Alpha MD sells one product whose title names a peptide and whose subtitle names two more, and it publishes two prices for it — one for California and one for everywhere else. Neither is a monthly rate: both buy what the page calls a ten to fifteen week supply, depending on the dose prescribed.
What Alpha MD charges
Sermorelin: $229.99 — for a supply the page calls ten to fifteen weeks, outside California; printed as a size option beside the California one
Sermorelin: $264.99 — the California figure for the same ten-to-fifteen-week supply; the seller prints both as two size options on one product
Alpha MD also sells 3 compounds this site boards without publishing a price for them: Ipamorelin (board ranks no provider), CJC-1295 (board ranks no provider) and NAD+.
Alpha MD is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
One product, three peptide names, two prices
The catalogue entry is titled with one peptide and subtitled, in brackets, with two others, so a reader scanning for three products finds one.
Beside it the seller prints two size options rather than two dose options: one for buyers outside California and one for buyers inside it.
The higher figure is attached to California by name on the page itself rather than surfacing at checkout.
Both options buy the same thing, so what separates them is geography — something almost nothing else in this comparison publishes.
The unit is a supply length, not a month
Each figure carries the words ten to fifteen weeks, and the page adds that the range depends on the dosage recommendation.
That is a supply window rather than a billing cycle, and its width is set by a prescribing decision the reader has not reached yet.
Both figures are therefore recorded here as non-monthly, with the supply language kept in the qualifier.
Converting either into a monthly rate would publish a number this seller has never printed and cannot be held to.
What the published figure actually buys
Two figures are published for the same product on the same page, and the only difference between them is the buyer's state.
On documentation the finding is more specific: not claimed; the certificate and third-party-testing pattern returned zero on both pages.
One hundred and thirty-seven of the two hundred and ten sellers here publish a figure somewhere on their own site, and this is one of them.
The host itself was checked in the same pass as everything above: 404 at a nonsense path, effective path identical to the requested one, which is what any absence recorded here rests on.
Three things this seller does not publish
One hundred and seventy-six of the two hundred and ten sellers here publish no state list at all, and this is one of them, so eligibility is settled inside an intake rather than before one.
Sixteen of the two hundred and ten sellers here name the facility that fills an order; this is one of the one hundred and ninety-four that do not, so there is no facility a reader can look up.
Four of the two hundred and ten sellers here describe lab work as included in what they charge, and this is not one of them.
It declares four of the sixteen compounds this site tracks, and sixty-one sellers here declare more, so it is a middling menu by the standards of this roster.
Who it's for
Buyers who want to know before an intake whether their state changes the price.
Readers comparing a supply-length price against a monthly one who want the difference stated rather than smoothed away.
Shoppers who want the growth-hormone secretagogue line out of a broader men's-health catalogue.
Anyone who prefers the qualifier printed next to the figure.
Who should look elsewhere
Readers who want a monthly rate, because neither published figure is one.
Buyers who need the compounding pharmacy named.
Anyone who wants a state list before starting an intake.
Shoppers looking for GHK-Cu, glutathione or tesamorelin, none of which is declared here.
Strengths
Publishes a separate figure for California buyers rather than surfacing the difference at checkout
Publishes a figure on its own site with the unit recorded beside it
Keeps its peptide offer separate from its other lines on the page
Answers the category question in plain language rather than in a disclaimer
Trade-offs
Both published figures buy a supply window whose width the page says depends on the dose prescribed
Publishes no corporate entity, so there is no company a reader can look up
Publishes no state list and names no dispensing pharmacy
Describes no lab work as included in what it charges
How we verified this
Read every page cited on this row as rendered text in a browser-equivalent fetch, with the response decompressed before any character was counted.
Fired a nonsense-path control at this host in the same run and compared the address requested with the address actually served, so no claim here rests on a status code alone.
Joined every text node before scanning for a dollar sign, so a figure split across nested elements could not read as an absence.
Read both size options on the product page and recorded the California figure separately rather than folding it into the lower one.
Kept the ten-to-fifteen-week language in each qualifier instead of deriving a monthly rate the seller has never published.
Read the shop index as well as the product page, and confirmed the other figures on it belong to non-peptide items.
Screened this seller in the live federal warning-letter record by entity and by brand, with a known-good positive control and a nonsense negative control fired in the same run.
Read the company column of every returned record rather than accepting a full-text match, and attached no letter on a name match.
Swept every attribute on the pages read for a certificate, not only the link targets, because certificates in this market hide in data attributes and lightbox images.
Re-counted the state-list, pharmacy-naming and lab-inclusion claims against the current roster rather than reusing figures from an earlier pass.
A provider to compare Alpha MD against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
No. Both figures buy what the page calls a ten to fifteen week supply, and it says the range depends on the dose recommended. Neither is divided into a monthly rate here.
Why are there two prices?
One is for buyers in California and one for buyers everywhere else. The seller prints both as size options on the same product.
Is the product one peptide or three?
It is sold as one item whose title names one peptide and whose subtitle names two more. All three are recorded as declared because the seller's own listing names all three.
Which states does it serve?
No list is published. The page distinguishes California from what it calls most states for pricing, which is a pricing statement rather than a coverage one.
Who fills the order?
No pharmacy is named on either page read.
Alpha MD is not a paid partner; this link may earn a commission if that changes. Full disclosure.